课题基金 / 基金详情

IMMUNOMODULATION IN SURGICAL/TRAUMA/BURN PATIENTS

IMMUNOMODULATION IN SURGICAL/TRAUMA/BURN PATIENTS
手术/创伤/烧伤患者的免疫调节
批准号:
3287714
负责人:
JOHN F HANSBROUGH
金额:
$14.26万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-04-01 至 1989-03-31

项目摘要

项目成果

JOHN F HANSBROUGH的其他基金

相似基金

相关文献

中文摘要
翻译
细胞介导的免疫缺陷以及炎症和抗体 反应无疑会导致患者感染和死亡 正在接受外科手术和遭受严重创伤和烧伤的人。 一直 在控制免疫反应和预防 免疫抑制后,这种伤害。 在我们以前的研究中, 记录了烧伤后小鼠的特异性免疫缺陷, 在骨骼创伤之后;我们还证明了特定的 药物治疗可以改善这些动物的免疫功能, 损伤(迟发性超敏反应,脾淋巴细胞“辅助/抑制” 比率和对败血症攻击的抗性)。 初步临床研究已 表明,一些相同的药物似乎可以防止改变, 大手术后循环淋巴细胞亚群。 该项目将确定特定的药物治疗是否可以改善 烧伤后动物和患者的额外免疫功能 烧伤、创伤和重大外科手术后。 毒品 将使用我们在以前的实验中所示的那些, 改善烧伤(小鼠)、骨骼创伤(小鼠)和严重 手术(人类)。 我们怀疑这些我们称之为 在该建议中,免疫调节药物通过阻断 抑制性淋巴细胞群的活化或增殖 损伤 实验旨在提供以下信息:1) 测定组胺-2受体拮抗剂、前列腺素 阻断剂,环磷酰胺,硝酸铈,影响多个免疫 功能在烧伤小鼠,使用不同的药物剂量; 2)确定 西咪替丁(组胺-2阻滞剂)和布洛芬( 前列腺素阻滞剂)影响大手术后的免疫功能 使用多种免疫功能措施的人类程序; 3) 确定相同药物对主要免疫功能后相似免疫功能的影响 人类非烧伤创伤,将损伤严重程度与特定 免疫反应; 4)确定相同药物对相似免疫反应的影响 烧伤后的功能,将烧伤的程度与 特异性免疫反应。
英文摘要
Defects in cell-mediated immunity and the inflammatory and antibody responses undoubtedly contribute to infections and mortality in patients undergoing surgery and who suffer major trauma and burn injury. There has been limited progress in controlling the immune responses and preventing immune depression after such injuries. In our previous studies we have documented specific immune deficits in mice following burn injury and following skeletal trauma; we have also demonstrated that specific pharmacologic therapy can improve immune functions in such animals after injury (delayed hypersensitivity, splenic lymphocyte "helper/suppressor" ratios, and resistance to septic challenge). Pilot clinical studies have shown that some of the same drugs appear to prevent alterations in circulating lymphocyte subpopulations after major surgical procedures. This project will determine if specific pharmacologic therapy can improve additional immune functions in animals after burn injury and in patients after burn injury, trauma and major surgical procedures. The drugs utilized will be those which we have shown in previous experiments to improve immunity following burns (mice), skeletal trauma (mice) and major surgery (humans). We suspect that these drugs, which we have termed immunmodulating drugs in this proposal, exert their effects by blocking activation or proliferation of suppressor lymphocyte populations after injury. Experiments are designed to provide the following information: 1) Determine the ability of histamine-2 receptor antagonists, prostaglandin blockers, cyclophosphamide, and cerium nitrate to affect multiple immune functions in burned mice, using varying drug dosages; 2) Determine the ability of cimetidine (a histamine-2 blocker) and ibuprofen (a prostaglandin blocker) to affect immune functions after major surgical procedures in humans, using multiple measures of immune function; 3) Determine effects of the same drugs on similar immune functions after major non-burn trauma in humans, correlating severity of injury with specific immune responses; 4) Determine effects of the same drugs on similar immune functions after burn injury, correlating the magnitude of burn injury with specific immune responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AS 013 IN LIPID EMULSION IN SUBJECTS W/ SEVERE LIMB ISCHEMIA
BURN/TRAUMA RESEARCH TRAINING GRANT
BURN/TRAUMA RESEARCH TRAINING GRANT
BURN/TRAUMA RESEARCH TRAINING GRANT
海外基金